Influence of atrial fibrillation subtypes on anticoagulant therapy in a high-risk older population: the FAI project.

Abstract

BACKGROUND AND AIM:

Benefits of oral anticoagulants (OAC) in atrial fibrillation (AF) patients with moderate-to-high risk of stroke are independent of AF pattern. We evaluated whether AF clinical subtype influenced OAC use in a representative sample of the Italian older population.

METHODS:

A cross-sectional examination of all subjects aged 65 + years from three general practices in northern, central, and southern Italy started in 2016. A double-screening procedure was followed by clinical and ECG confirmation. Patients were categorized as having paroxysmal, persistent, or permanent AF. OAC use was evaluated in confirmed AF patients.

RESULTS:

The sample included 6016 subjects. Excluding 235 non-eligible, participation was 78.3%, which left 4528 participants (mean age 74.5 ± 6.8 years, 47.2% men). Overall, 319 AF cases were identified: 43.0% had paroxysmal, 21.3% persistent, and 35.7% permanent AF. Frequency of OAC therapy was 91.2% in permanent, 85.3% in persistent, and only 43.0% in paroxysmal AF (P < 0.001). In multivariate analysis, controlled for baseline variables and risk scales, persistent and permanent AF were associated with a significant increase in the likelihood of receiving OAC compared with paroxysmal AF (P < 0.001). This was confirmed for permanent AF also in multivariate analyses considering separately vitamin K antagonists or direct-acting oral anticoagulants (OR, 4.37, 95% CI, 2.43-7.85; and 1.92, 95% CI, 1.07-3.42, respectively) and for persistent AF and direct-acting oral anticoagulants (OR, 4.33, 95% CI, 2.30-8.15).

CONCLUSIONS:

In a population-based survey, AF pattern was an independent predictor of OAC treatment. Paroxysmal AF is still perceived as carrying a lower risk of vascular events.

• Authors: Antonio Di Carlo, Fabio Mori, Domenico Consoli, Leonardo Bellino, Augusto Zaninelli, Marzia Baldereschi, Maria Grazia D'Alfonso, Chiara Gradia, Alessandro Cattarinussi, Bruno Sgherzi, Giovanni Pracucci, Benedetta Piccardi, Bianca Maria Polizzi, Domenico Inzitari, National Research Program: Progetto FAI. La Fibrillazione Atriale in Italia
• Journal: Aging clinical and experimental research (Aging Clin Exp Res) Vol. 34 Issue 9 Pg. 2185-2194 (Sep 2022) ISSN: 1720-8319 [Electronic] Germany
• PMID: 35543807 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Anticoagulants
• Factor Xa Inhibitors

Topics

• Administration, Oral
• Aged
• Aged, 80 and over
• Anticoagulants (therapeutic use)
• Atrial Fibrillation (complications)
• Cross-Sectional Studies
• Factor Xa Inhibitors (therapeutic use)
• Female
• Humans
• Male
• Risk Factors
• Stroke (epidemiology, etiology, prevention & control)